Literature DB >> 3275427

An analysis of the role of microfilaments in the establishment and maintenance of asymmetry in Caenorhabditis elegans zygotes.

D P Hill1, S Strome.   

Abstract

Microfilaments are needed to generate asymmetry during the first cell cycle in Caenorhabditis elegans zygotes. To investigate when and how microfilaments participate in this process, we have "pulsed" zygotes with the microfilament inhibitor cytochalasin D (CD) at different times during the cell cycle. We have shown that microfilaments are only required during a narrow time interval approximately three-quarters of the way through the first cell cycle for the manifestations of asymmetry that occur during and subsequent to this interval. When CD treatment spans this critical time interval, pseudocleavage, pronuclear migration, germ-granule segregation (all of which occur during the interval), and movement of the mitotic spindle to an asymmetric position (which occurs later in the cell cycle) are perturbed. In contrast, embryos briefly treated with CD before or after the critical time interval manifest normal asymmetry. Our results suggest that in C. elegans microfilaments participate in the generation of zygotic asymmetry by providing spatial cues and/or serving as a part of the necessary machinery only during a brief period in the first cell cycle, and are not required to maintain asymmetries that have already been established.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3275427     DOI: 10.1016/0012-1606(88)90060-7

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  34 in total

1.  Polarization of the C. elegans zygote proceeds via distinct establishment and maintenance phases.

Authors:  Adrian A Cuenca; Aaron Schetter; Donato Aceto; Kenneth Kemphues; Geraldine Seydoux
Journal:  Development       Date:  2003-04       Impact factor: 6.868

2.  Isolation of actin-associated proteins from Caenorhabditis elegans oocytes and their localization in the early embryo.

Authors:  R V Aroian; C Field; G Pruliere; C Kenyon; B M Alberts
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

3.  Mutations affecting the meiotic and mitotic divisions of the early Caenorhabditis elegans embryo.

Authors:  P E Mains; K J Kemphues; S A Sprunger; I A Sulston; W B Wood
Journal:  Genetics       Date:  1990-11       Impact factor: 4.562

4.  par-4, a gene required for cytoplasmic localization and determination of specific cell types in Caenorhabditis elegans embryogenesis.

Authors:  D G Morton; J M Roos; K J Kemphues
Journal:  Genetics       Date:  1992-04       Impact factor: 4.562

5.  Functions of the Caenorhabditis elegans regulatory myosin light chain genes mlc-1 and mlc-2.

Authors:  A M Rushforth; C C White; P Anderson
Journal:  Genetics       Date:  1998-11       Impact factor: 4.562

6.  Dynamic localization of C. elegans TPR-GoLoco proteins mediates mitotic spindle orientation by extrinsic signaling.

Authors:  Adam D Werts; Minna Roh-Johnson; Bob Goldstein
Journal:  Development       Date:  2011-09-08       Impact factor: 6.868

7.  Localization and segregation of lineage-specific cleavage potential in embryos of Caenorhabditis elegans.

Authors:  Einhard Schierenberg
Journal:  Rouxs Arch Dev Biol       Date:  1988-08

8.  PAR-3 oligomerization may provide an actin-independent mechanism to maintain distinct par protein domains in the early Caenorhabditis elegans embryo.

Authors:  Adriana T Dawes; Edwin M Munro
Journal:  Biophys J       Date:  2011-09-20       Impact factor: 4.033

9.  NMY-2 maintains cellular asymmetry and cell boundaries, and promotes a SRC-dependent asymmetric cell division.

Authors:  Ji Liu; Lisa L Maduzia; Masaki Shirayama; Craig C Mello
Journal:  Dev Biol       Date:  2010-01-06       Impact factor: 3.582

10.  CGEF-1 and CHIN-1 regulate CDC-42 activity during asymmetric division in the Caenorhabditis elegans embryo.

Authors:  Kraig T Kumfer; Steven J Cook; Jayne M Squirrell; Kevin W Eliceiri; Nina Peel; Kevin F O'Connell; John G White
Journal:  Mol Biol Cell       Date:  2009-11-18       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.